Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2014 Nov 5

PMID 25367883

Citations 69

Authors

Wei Wang

Mingchang Li

Qianxue Chen

Jian Wang

Affiliations

Soon will be listed here.

Abstract

Intracerebral hemorrhagic transformation (HT) is well recognized as a common cause of hemorrhage in patients with ischemic stroke. HT after acute ischemic stroke contributes to early mortality and adversely affects functional recovery. The risk of HT is especially high when patients receive thrombolytic reperfusion therapy with tissue plasminogen activator, the only available treatment for ischemic stroke. Although many important publications address preclinical models of ischemic stroke, there are no current recommendations regarding the conduct of research aimed at understanding the mechanisms and prediction of HT. In this review, we discuss the underlying mechanisms for HT after ischemic stroke, provide an overview of the models commonly used for the study of HT, and discuss biomarkers that might be used for the early detection of this challenging clinical problem.

Citing Articles

Alpha‑Asarone Ameliorates Neuronal Injury After Ischemic Stroke and Hemorrhagic Transformation by Attenuating Blood-Brain Barrier Destruction, Promoting Neurogenesis, and Inhibiting Neuroinflammation.

Luo L, Hu Q, Yan R, Gao X, Zhang D, Yan Y Mol Neurobiol. 2024; 62(4):5252-5272.

PMID: 39531192 DOI: 10.1007/s12035-024-04596-5.

Dexmedetomidine alleviates blood-brain barrier disruption in rats after cerebral ischemia-reperfusion by suppressing JNK and p38 MAPK signaling.

Zhu C, Wang D, Chang C, Liu A, Zhou J, Yang T Korean J Physiol Pharmacol. 2024; 28(3):239-252.

PMID: 38682172 PMC: 11058545. DOI: 10.4196/kjpp.2024.28.3.239.

Innovations in Breaking Barriers: Liposomes as Near-Perfect Drug Carriers in Ischemic Stroke Therapy.

Zhang Q, Huang S, Liu X, Wang W, Zhu Z, Chen L Int J Nanomedicine. 2024; 19:3715-3735.

PMID: 38681090 PMC: 11046314. DOI: 10.2147/IJN.S462194.

The combination model of serum occludin and clinical risk factors improved the efficacy for predicting hemorrhagic transformation in stroke patients with recanalization.

Yuan S, Ma Q, Hou C, Li W, Liu K, Ji X Heliyon. 2024; 10(2):e25052.

PMID: 38312551 PMC: 10834999. DOI: 10.1016/j.heliyon.2024.e25052.

The early predictive value of platelet-to-lymphocyte ratio to hemorrhagic transformation of young acute ischemic stroke.

Wen H, Wang N, Lv M, Yang Y, Liu H Asian Biomed (Res Rev News). 2024; 17(6):267-272.

PMID: 38161346 PMC: 10754501. DOI: 10.2478/abm-2023-0069.

References

England T, Bath P, Sare G, Geeganage C, Moulin T, ONeill D . Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial. Stroke. 2010; 41(12):2834-9. DOI: 10.1161/STROKEAHA.109.573063. View

Gursoy-Ozdemir Y, Can A, Dalkara T . Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke. 2004; 35(6):1449-53. DOI: 10.1161/01.STR.0000126044.83777.f4. View

Hata R, Maeda K, Hermann D, Mies G, Hossmann K . Evolution of brain infarction after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 2000; 20(6):937-46. DOI: 10.1097/00004647-200006000-00006. View

Nour M, Scalzo F, Liebeskind D . Ischemia-reperfusion injury in stroke. Interv Neurol. 2014; 1(3-4):185-99. PMC: 4031777. DOI: 10.1159/000353125. View

Jha R, Battey T, Pham L, Lorenzano S, Furie K, Sheth K . Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke. Stroke. 2014; 45(4):1040-5. PMC: 3970574. DOI: 10.1161/STROKEAHA.113.004627. View

Rosell A, Cuadrado E, Ortega-Aznar A, Hernandez-Guillamon M, Lo E, Montaner J . MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke. 2008; 39(4):1121-6. DOI: 10.1161/STROKEAHA.107.500868. View

Foerch C, Wunderlich M, Dvorak F, Humpich M, Kahles T, Goertler M . Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke. 2007; 38(9):2491-5. DOI: 10.1161/STROKEAHA.106.480111. View

Bokura H, Saika R, Yamaguchi T, Nagai A, Oguro H, Kobayashi S . Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals. Stroke. 2011; 42(7):1867-71. DOI: 10.1161/STROKEAHA.110.601922. View

Murata Y, Rosell A, Scannevin R, Rhodes K, Wang X, Lo E . Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke. 2008; 39(12):3372-7. PMC: 3705574. DOI: 10.1161/STROKEAHA.108.514026. View

10.

Cocho D, Borrell M, Marti-Fabregas J, Montaner J, Castellanos M, Bravo Y . Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator. Stroke. 2006; 37(4):996-9. DOI: 10.1161/01.STR.0000206461.71624.50. View

11.

Lakhan S, Kirchgessner A, Tepper D, Leonard A . Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol. 2013; 4:32. PMC: 3615191. DOI: 10.3389/fneur.2013.00032. View

12.

Scalzo F, Alger J, Hu X, Saver J, Dani K, Muir K . Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging features. Magn Reson Imaging. 2013; 31(6):961-9. PMC: 3676704. DOI: 10.1016/j.mri.2013.03.013. View

13.

Pang P, Lu B . Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF. Ageing Res Rev. 2004; 3(4):407-30. DOI: 10.1016/j.arr.2004.07.002. View

14.

Ito A, Niizuma K, Shimizu H, Fujimura M, Hasumi K, Tominaga T . SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice. Brain Res. 2014; 1578:38-48. DOI: 10.1016/j.brainres.2014.07.004. View

15.

Del Zoppo G, Frankowski H, Gu Y, Osada T, Kanazawa M, Milner R . Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation. J Cereb Blood Flow Metab. 2012; 32(5):919-32. PMC: 3345906. DOI: 10.1038/jcbfm.2012.11. View

16.

Souvenir R, Fathali N, Ostrowski R, Lekic T, Zhang J, Tang J . Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia. Neurobiol Dis. 2011; 44(1):28-37. PMC: 3153566. DOI: 10.1016/j.nbd.2011.05.020. View

17.

Bevilacqua M . Endothelial-leukocyte adhesion molecules. Annu Rev Immunol. 1993; 11:767-804. DOI: 10.1146/annurev.iy.11.040193.004003. View

18.

Hartz A, Bauer B, Soldner E, Wolf A, Boy S, Backhaus R . Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke. 2011; 43(2):514-23. PMC: 5761312. DOI: 10.1161/STROKEAHA.111.627562. View

19.

. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24):1581-7. DOI: 10.1056/NEJM199512143332401. View

20.

Kitashoji A, Egashira Y, Mishiro K, Suzuki Y, Ito H, Tsuruma K . Cilostazol ameliorates warfarin-induced hemorrhagic transformation after cerebral ischemia in mice. Stroke. 2013; 44(10):2862-8. DOI: 10.1161/STROKEAHA.113.001183. View